Featured Jobs
|
Senior Specialist 401k Recordkeeping T Bank N.A.
|
|
Retirement Solutions Specialists
|
|
Defined Contribution Account Manager Nova 401(k) Associates
|
|
Greenline Wealth Management
|
|
TPA Retirement Plan Consultant EPIC RPS (TPA/DPS)
|
|
Fringe Benefit Group
|
|
Pollard & Associates
|
|
Defined Contributions Compliance Consultant Loren D. Stark Company (LDSCO)
|
|
New York City District Council of Carpenters Benefit Funds
|
|
Retirement Planners and Administrators (RPA)
|
|
Great Lakes Pension Associates, Inc.
|
|
Defined Benefit Combo Cash Balance Compliance Consultant Loren D. Stark Company (LDSCO)
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
Key Driver of High Rx Spending: Brand-Name Drug Prices
The Commonwealth Fund 
Nov. 18, 2021 "High U.S. drug prices are a financial strain for patients, employers, and state and federal governments. [A series of charts presents] the findings from a number of studies on prescription drug costs and spending in the United States with other high-income countries to reveal the main culprit: high U.S. prices for brand-name drugs." |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |
